Home Search
organoid - search results
If you're not happy with the results, please do another search
CIART Gene Found to Play Key Role in SARS-CoV-2 Infection
The gene CIART is a major factor in the establishment of a COVID-19 infection, according to a new study.
AI Algorithm Reveals New Targets in Half of All Glioblastoma Tumors
A new algorithm leveraging artificial intelligence machine learning appears to reveal the key drivers of two types of glioblastoma multiforme (GBM) that together represent half of all GBMs.
Activity of Genetic Contributor to Lung Squamous Cell Carcinoma Detailed
A research team has identified a gene that drive the development of lung squamous cell carninoma (LUSC)—a major subtype of lung cancer with limited treatment options.
Can COVID-19 Reboot Drug Repurposing?
It seems like a slam dunk. Why not repurpose already approved or well-studied drug candidates for conditions where treatments are desperately needed? Wouldn’t that...
Cytokine
ACROBiosystems has independently developed a series of related tools, which are ideal for T cell activation and expansion in vitro and better facilitate the development of cell therapy.
Circadian Clock Disruption Linked with Colorectal Cancer Rise
Circadian clock disruption, such as that occurring through shift work, could contribute to the alarming rise in young-onset colorectal cancer.
Network-Based Model Points to Potential New COVID-19 Drugs
ViroTreat, a model for rapid identification of antiviral drugs, has been validated by DarwinHealth scientists and their international colleagues.
Key Protein In Pancreatic Cancer Growth and Spread Found
A key genetic regulator of human pancreatic cancer has been identified that can fuel or reverse the ability of tumor cells to change into a more aggressive subtype.
Cancer Cell Latency a Key Factor in Colon Cancer Relapse After Chemotherapy
Scientists have discovered that tumor stem cells with Mex3a protein activity remain in a state of latency that confers resistance to chemotherapy.
Faeth Therapeutics Raises $47M to Advance Its Cancer Metabolism Treatment Approach
Proceeds will be used to fund clinical trials that will combine nutrient control, therapeutics, and digital tools to inhibit cancer metabolism.
